RXO INC (RXO)
(Delayed Data from NYSE)
$31.16 USD
+0.71 (2.33%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $31.17 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Income Statements
Fiscal Year end for RXO INC falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 3,927 | 4,796 | 4,689 | 3,357 | NA |
Cost Of Goods | 3,202 | 3,850 | 3,873 | 2,742 | NA |
Gross Profit | 725 | 946 | 816 | 615 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 686 | 823 | 624 | 555 | 0 |
Income After Depreciation & Amortization | 39 | 123 | 192 | 60 | 0 |
Non-Operating Income | -3 | 0 | -1 | -3 | NA |
Interest Expense | 32 | 4 | 0 | 0 | NA |
Pretax Income | 4 | 119 | 191 | 57 | NA |
Income Taxes | 0 | 27 | 41 | 14 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | 4 | 92 | 150 | 43 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | 4 | 92 | 150 | 43 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 106 | 209 | 273 | 136 | 0 |
Depreciation & Amortization (Cash Flow) | 67 | 86 | 81 | 76 | NA |
Income After Depreciation & Amortization | 39 | 123 | 192 | 60 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 119.46 | 115.79 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | 0.30 | 1.56 | NA | NA | NA |
Diluted Net EPS (GAAP) | 0.03 | 0.79 | NA | NA | NA |
Fiscal Year end for RXO INC falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 913.00 | 978.00 | 976.00 | 963.00 |
Cost Of Goods | NA | 752.00 | 799.00 | 801.00 | 782.00 |
Gross Profit | NA | 161.00 | 179.00 | 175.00 | 181.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 173.00 | 165.00 | 169.00 | 167.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -12.00 | 14.00 | 6.00 | 14.00 |
Non-Operating Income | NA | -1.00 | -2.00 | -1.00 | 0.00 |
Interest Expense | NA | 8.00 | 8.00 | 8.00 | 8.00 |
Pretax Income | NA | -21.00 | 4.00 | -3.00 | 6.00 |
Income Taxes | NA | -6.00 | 2.00 | -2.00 | 3.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -15.00 | 2.00 | -1.00 | 3.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -15.00 | 2.00 | -1.00 | 3.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 117.22 | 119.58 | 116.97 | 119.46 |
Diluted EPS Before Non-Recurring Items | NA | -0.03 | 0.06 | 0.05 | 0.08 |
Diluted Net EPS (GAAP) | NA | -0.13 | 0.01 | -0.01 | 0.03 |